The prevalence of sleep related upper airway obstruction (UAO) 
and 4.9 years (median [1] [2] [3] [4] , underwent full clinical assessment for UAO including parental questionnaires and overnight tape recordings of chest wall movements and arterial oxygen saturation (Sao2). Compared with controls, children with Down's syndrome had (a) an increased incidence of stridor and chest wall recession during sleep, (b) an increased frequency of a pattern on inspiration indicating increased upper airway resistance, (c) a reduced baseline oxygen saturation (having excluded recordings on four children with potential for right to left intracardiac shunting), and (d) an increased number of episodes with Sao2<90% despite continued chest wall movements.
At their initial assessment seven children (22%) had evidence of UAO. The 18 youngest children (-1-7 years) underwent repeated recordings and clinical assessment until they had all reached 2 years of age. A further three were found to have developed UAO.
Sleep related UAO is a common problem in children with Down's syndrome, occurring in 10 of 32 (31%) of this population based sample.
Previous reports have shown that individuals with Down's syndrome are subject to upper airway obstruction (UAO).'" Features of the anatomy of the upper airway are thought to predispose to this complication,2 which when severe may lead to pulmonary hypertension and heart failure. 7 In any child, UAO may be associated with poor growth, sleep disturbance, day time lethargy, chronic upper respiratory problems, and poor developmental progress. 8 If present in a child with Down's syndrome, these may add to the total load of handicap suffered. 9 As UAO may either increase in severity during, or only be present in, sleep, the patient suspected of suffering this disorder must be investigated while asleep.
The present study aims to determine the prevalence of UAO in a population of children with Down's syndrome in a well defined geographical area by using questionnaires and overnight multichannel physiological recordings. The subsequent clinical assessment and outcome are also described.
Subjects
The study consisted of three parts: (i) a casecontrolled study of signs of UAO obtained by questionnaires administered to [ 4) .
One subject (case 30) had undergone adenoidectomy for recurrent otitis media and one subject (case 14) had severe UAO in the neonatal period, as observed by Mugliston and Mitchell,'0 but this had subsequently resolved.
No other subject had undergone investigation or treatment for UAO, tonsillectomy, or adenoidectomy for any reason.
Twelve children (38%) were known to have congenital heart disease: five had ventricular septal defects, two had atrioventricular septal defects, three had complex structural defects, and one each had a secundum atrial septal defect and a patent arterial duct. Two of the 12 had undergone palliative surgery. Because cardiac function could have affected the respiratory measurements, a paediatric cardiologist, blind to the study findings, reviewed the case notes of the 12 children. At the time of the recordings, four children had a defect which might have resulted in baseline arterial hypoxaemia (Sao2<95%) (cases 1, 9, 15, and 22) and five children were considered to be tachypnoeic (cases 1, 2, 9, 15, and 22).
CONTROLS
Two sets of healthy infants and children with-out Down's syndrome were used as controls. For the questionnaire, 26 controls of similar age to the children with Down's syndrome were selected randomly; they ranged in age from 0 1 to 5 6 years (median 2 0) and there were 15 boys and 11 girls. For the overnight recordings, 32 different controls were selected randomly and matched individually to the subjects' ages; their ages ranged from 0 1 to 5-7 years (median 1 0) and there were 16 boys and 16 girls.
Methods

QUESTIONNAIRE
A structured interview was used to question parents about the presence of six clinical signs during sleep which from previous experience were known to be associated with UAO.4 These were inspiratory stridor (snoring), chest wall recession, sudden wakenings with a startle or gasp, restlessness, breathing through the mouth, and excessive sweating. The significance of differences in the incidence of these signs between children with Down's syndrome and controls was tested by Wilcoxon rank sum or x2 tests.
RECORDINGS
Twelve hour overnight tape recordings were performed on each child with Down's syndrome and each control (at the time of the above interviews for the subjects). Recordings included the following signals: (1) (a) The presence of the pattern on the chest wall movement record indicating increased inspiratory resistance (false negative results may be obtained if tachypnoea is present and the five cases with congenital heart disease resulting in this pattern of breathing were, therefore, excluded from this analysis).
(b) Baseline Sao2, measured at the end inspiratory peak of five successive breaths in the centre of each period of regular pattern breathing, in an area separated by at least 10 seconds from disturbance of the chest wall movement by sigh or apnoeic pause. The mean of these measurements was calculated.
(c) Episodes of desaturation in which Sao2 fell to -90%, the duration of each being measured. Apnoeic pauses were identified where there was a cessation of chest wall movement with a duration of ¢4 seconds. Episodes of desaturation were discounted if they showed a temporal relationship with such pauses: that is, where the beginnings of a pause and of a subsequent desaturation 690% were separated by 2-12 seconds. This excluded the episodic desaturation that has been demonstrated to follow frequently and normally apnoeic pauses in healthy infants.'3 The remaining episodic desaturations, that is, those associated with continued chest wall movements, were regarded as probably resulting from UAO. The durations of these episodes were summed in each breathing pattern separately, and expressed as durations per hour of artefact free signal. They were separated because Sao2 instability has been demonstrated to be determined by breathing pattern, being reduced in regular pattern breathing. '3 The significance of the differences for baseline Sao2, episodic hypoxaemia, and for the presence of increased inspiratory resistance between the children with Down's syndrome and controls was tested by the For non-regular breathing pattern alone, the frequency of episodic desaturation ranged from 0 to 219-1 s/h (median 3-45) for the children with Down's syndrome and from 0 to 4-9 s/h (median 0) for the controls (p<00001), Wilcoxon). The frequency of episodic desaturation in regular breathing pattern alone for the 26 children with Down's syndrome ranged from 0 to 140x7 s/h (median 1-4) but for the controls only one score was greater than 0 (range 0 to 1-3) (p<0l0001, Wilcoxon).
CLINICAL ASSESSMENT FOR UAO
The first assessment indicated UAO in seven of the 32 children with Down's syndrome (cases 11, 12, 14, 18, 21, 23, and 29). The median age of these seven children was 1-6 years (range 0-7-4 2). At different ages, the proportion of children with Down's syndrome who demonstrated UAO was as follows: 1/11 (9%) in the first year of life, 4/11 (36%) in the second and third years, and 2/10 (20%) in the fourth and fifth years.
The results from these seven children were compared with those from the children with Down's syndrome (n=25) who had no, or only mild, evidence of UAO. The median number of clinical signs in the children with UAO was three compared with one. Two of the seven had a parental report of chest wall recession and six had inspiratory stridor, and one subject was reported as having no clinical signs (case 14) . The seven children, none of whom had a cardiac defect considered to cause baseline hypoxaemia, had a lower median baseline Sao2 (95-5 v 97 4%). In addition, six of the seven had values below the lowest observed baseline Sao2 in the healthy controls. Compared with the children with Down's syndrome without UAO, the seven with UAO had more episodic desaturations in both non-regular breathing (median 24-6 v 2-4 s/h) and regular breathing (9-0 v 0-5 s/h).
A second clinical assessment was performed in 18 children with Down's syndrome, and a third in eight of these children. Three additional children (cases 8, 13, and 15) showed UAO at a follow up assessment, having not shown this on their previous recordings. All showed this after infancy (at ages 25, 24, and 18 months respectively). The number of clinical signs these children reported had increased from the number reported at their first recording (from 1, 1, and 3, to 4, 3, and 4 respectively); all showed inspiratory stridor and chest wall recession.
Seven children, followed later by a further three, were thus identified as having UAO (31% of the original cohort). All 10 were offered further investigation, but only eight sets of parents wished to proceed. Three patients underwent repeated clinical assessment and demonstrated no need for immediate intervention, two patients showed apparently spontaneous resolution, and three (9% of the cohort) underwent adenotonsillectomy at 30, 30, and 50 months of age. Six of the 10 children stayed in the programme and their full histories until their fifth birthdays are known. Two of the 10 children with UAO (cases 11 and 14) had moved from the area and were followed up by telephone at around 5 years of age; on contact both were found to need surgery to alleviate UAO (see histories below).
After the end of the formal part of the study two of the younger children, who were considered not to show UAO during the study period, have subsequently developed symptoms and, without formal clinical assessment, underwent adenotonsillectomy at 3 and 4 years ofage respectively. Both children had a resultant diminution in their symptoms of UAO. One further child has also undergone adenotonsillectomy, at age 7 years, because of recurrent respiratory infections.
The cohort is now aged between 5 and 10 years. Overall, nine (28%) have undergone adenoidectomy or adenotonsillectomy: one before, and three during, the study period and a further five by the end of the recent follow up.
The case histories of six of the 10 children with UAO, highlighting certain aspects of management, are given below. showed adenoidal obstruction of the nasopharynx and oropharyngeal obstruction from palatine tonsils collapsing to the midline. Adenotonsillectomy was performed at age 60 months and was followed by disappearance of both snoring and nocturnal enuresis and a considerable reduction in both sleep disturbance and daytime somnolence. An assessment after surgery showed that UAO had almost completely resolved.
Case 12
This girl had signs of UAO at 1 year of age that were confirmed by a clinical assessment.
Nasendoscopy showed obstruction at the tongue base, with oropharyngeal shutdown resulting from tongue base and oropharyngeal incompetence. There was no adenotonsillar encroachment and her hypopharynx and larynx were normal. This obstruction would have been difficult to resolve. The treatment options were still under discussion when reassessment at the age of 24 months showed an appreciable lessening of UAO. This confirmed an improvement noted from clinical signs and no action was considered necessary.
Case 13
At 12 months of age this girl showed no evidence of UAO. At 24 months, however, clinical assessment showed severe obstruction that was confirmed by a history of increasing signs during her second year of life. At nasendoscopy it was only possible to examine the airway with the subject on her side because of the severity of the obstruction. The examination showed tonsillar shutdown and obstruction at the tip of the epiglottis, while the larynx and subglottis were normal. Before a routine adenotonsillectomy she suffered a choking and cyanotic episode at home, necessitating resuscitation by an ambulance crew. Surgery was performed urgently at 30 months of age. She was subsequently reported to be more alert, physically stronger, sleeping better, and had a postoperative growth spurt. At age 5 years she presented with sleep disturbance but clinical assessment showed that this was not due to UAO.
Case 14
This boy had severe UAO in the neonatal period but then recovered. An assessment at 15 months showed some UAO but his family reported no clinical signs. By 27 months of age he had developed signs and an assessment at that age showed severe obstruction. He underwent nasendoscopy which showed a significant adenoid pad, with 80% obstruction of the posterior choana, and large pallatine tonsils. The epiglottis was posterior, with the aryepiglottic folds being drawn with inspiration into the laryngeal inlet. The vocal cords, subglottic region, and trachea were normal. As he still had few symptoms an expectant policy was adopted. He moved from the area, resulting in no further contact until age 5 years, when he continued to manifest severe symptoms of UAO with snoring, chest wall recession, and frequent wakenings from sleep. An assessment confirmed severe UAO and nasendoscopy showed a modest adenoidal pad obstructing 50% of the nasopharynx. The tonsils were non-obstructive and adenoidectomy alone was, therefore, performed. During the weeks after surgery he had no apparent relief from his signs and his treatment is currently being reviewed.
Case 15
This boy had congenital heart disease (secundum atrial and ventricular septal defects).
Assessments at age 2 and 12 months showed no evidence of UAO, but baseline Sao2 had fallen over time and was thought to be due to his heart disease. At 18 months of age he had signs of UAO, but his recording showed tachypnoea (respiratory rate 51 breaths per minute in regular pattern breathing), making an assessment of inspiratory resistance difficult. A video recording during sleep showed stridor and chest wall recession. He underwent corrective cardiac surgery after which he had fewer clinical signs of UAO. He continued to thrive and develop well with only mild signs of UAO.
Discussion
The prevalence of UAO exacerbated by, or only present during, sleep in young children with Down's syndrome is high. Overall 10 children (31%) had obstruction identified during the study period: seven on their first recordings and three on repeated recordings. This complication was most prevalent in the second and third years of life. In children without Down's syndrome, sleep related UAO is related to the emergence of lymphoid hyperplasia, is uncommon in infancy, and most frequent between the ages of 1 and 3 years. 4 Our experience with Down's syndrome reflects this observation and lymphoid hypertrophy did indeed prove to be a major contributing factor. 22 The rate of adenotonsillectomy in this group of children with Down's syndrome was high with 28% known to have undergone either this procedure or adenoidectomy alone at some point in their lives (9% during the study period). This compares with a rate in Britain of 0-8% of the total paediatric population for adenotonsillectomy.23 Our children also appeared to need surgery earlier: the national peak period for adenotonsillectomy is 5 to 9 years of age24 but six of our nine subjects underwent procedures well before their fifth birthday.
A small minority of children with Down's syndrome and life threatening UAO may require tracheostomy. In our limited experience this is successful in overcoming pulmonary hypertension but presents severe difficulties for the children's parents, particularly in relation to the high amount of mucosal secretions associated with Down's syndrome.4 Improvements are needed in surgical and non-surgical alternatives (for example, the use of nasopharyngeal tubes or nasal mask continuous positive airway pressure) if such an extreme, but sometimes essential, solution is to be avoided.
Sleep related UAO is a major and, in most cases, treatable cause of additional morbidity in children with Down's syndrome. Diagnosis is relatively straightforward, but there is a need for better treatment for the severe obstruction that may occur at the base of the tongue.
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